The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sacral Nerve Stimulation Market Research Report 2025
Synopsis
Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor.
The global Sacral Nerve Stimulation market was valued at US$ 742.6 million in 2023 and is anticipated to reach US$ 1586.1 million by 2030, witnessing a CAGR of 11.0% during the forecast period 2024-2030.
The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is completely new to the market in APAC as implantable SNS devices are more popular compared with external SNS devices. With the introduction of new SNS devices by companies such as Nuvectra and Axonics Modulation Technologies, this segment is anticipated to have a positive outlook in the coming years.
This report aims to provide a comprehensive presentation of the global market for Sacral Nerve Stimulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sacral Nerve Stimulation.
Report Scope
The Sacral Nerve Stimulation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sacral Nerve Stimulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sacral Nerve Stimulation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
Abbott
Axonics Modulation Technologies
Nuvectra
Cogentix Medical
Cyberonics
Uroplasty, Inc
Neuropace
IntraPace, Inc
Codman & Shurtleff, Inc
Segment by Type
Implantable SNS
External SNS
Segment by Application
Hospitals
Clinics
ASCs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sacral Nerve Stimulation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor.
The global Sacral Nerve Stimulation market was valued at US$ 742.6 million in 2023 and is anticipated to reach US$ 1586.1 million by 2030, witnessing a CAGR of 11.0% during the forecast period 2024-2030.
The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is completely new to the market in APAC as implantable SNS devices are more popular compared with external SNS devices. With the introduction of new SNS devices by companies such as Nuvectra and Axonics Modulation Technologies, this segment is anticipated to have a positive outlook in the coming years.
This report aims to provide a comprehensive presentation of the global market for Sacral Nerve Stimulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sacral Nerve Stimulation.
Report Scope
The Sacral Nerve Stimulation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sacral Nerve Stimulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sacral Nerve Stimulation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
Abbott
Axonics Modulation Technologies
Nuvectra
Cogentix Medical
Cyberonics
Uroplasty, Inc
Neuropace
IntraPace, Inc
Codman & Shurtleff, Inc
Segment by Type
Implantable SNS
External SNS
Segment by Application
Hospitals
Clinics
ASCs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sacral Nerve Stimulation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sacral Nerve Stimulation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Implantable SNS
1.2.3 External SNS
1.3 Market by Application
1.3.1 Global Sacral Nerve Stimulation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 ASCs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sacral Nerve Stimulation Market Perspective (2019-2030)
2.2 Sacral Nerve Stimulation Growth Trends by Region
2.2.1 Global Sacral Nerve Stimulation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sacral Nerve Stimulation Historic Market Size by Region (2019-2024)
2.2.3 Sacral Nerve Stimulation Forecasted Market Size by Region (2025-2030)
2.3 Sacral Nerve Stimulation Market Dynamics
2.3.1 Sacral Nerve Stimulation Industry Trends
2.3.2 Sacral Nerve Stimulation Market Drivers
2.3.3 Sacral Nerve Stimulation Market Challenges
2.3.4 Sacral Nerve Stimulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sacral Nerve Stimulation Players by Revenue
3.1.1 Global Top Sacral Nerve Stimulation Players by Revenue (2019-2024)
3.1.2 Global Sacral Nerve Stimulation Revenue Market Share by Players (2019-2024)
3.2 Global Sacral Nerve Stimulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sacral Nerve Stimulation Revenue
3.4 Global Sacral Nerve Stimulation Market Concentration Ratio
3.4.1 Global Sacral Nerve Stimulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sacral Nerve Stimulation Revenue in 2023
3.5 Sacral Nerve Stimulation Key Players Head office and Area Served
3.6 Key Players Sacral Nerve Stimulation Product Solution and Service
3.7 Date of Enter into Sacral Nerve Stimulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sacral Nerve Stimulation Breakdown Data by Type
4.1 Global Sacral Nerve Stimulation Historic Market Size by Type (2019-2024)
4.2 Global Sacral Nerve Stimulation Forecasted Market Size by Type (2025-2030)
5 Sacral Nerve Stimulation Breakdown Data by Application
5.1 Global Sacral Nerve Stimulation Historic Market Size by Application (2019-2024)
5.2 Global Sacral Nerve Stimulation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sacral Nerve Stimulation Market Size (2019-2030)
6.2 North America Sacral Nerve Stimulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sacral Nerve Stimulation Market Size by Country (2019-2024)
6.4 North America Sacral Nerve Stimulation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sacral Nerve Stimulation Market Size (2019-2030)
7.2 Europe Sacral Nerve Stimulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sacral Nerve Stimulation Market Size by Country (2019-2024)
7.4 Europe Sacral Nerve Stimulation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sacral Nerve Stimulation Market Size (2019-2030)
8.2 Asia-Pacific Sacral Nerve Stimulation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sacral Nerve Stimulation Market Size by Region (2019-2024)
8.4 Asia-Pacific Sacral Nerve Stimulation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sacral Nerve Stimulation Market Size (2019-2030)
9.2 Latin America Sacral Nerve Stimulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sacral Nerve Stimulation Market Size by Country (2019-2024)
9.4 Latin America Sacral Nerve Stimulation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sacral Nerve Stimulation Market Size (2019-2030)
10.2 Middle East & Africa Sacral Nerve Stimulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sacral Nerve Stimulation Market Size by Country (2019-2024)
10.4 Middle East & Africa Sacral Nerve Stimulation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Sacral Nerve Stimulation Introduction
11.1.4 Medtronic Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Detail
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Sacral Nerve Stimulation Introduction
11.2.4 Boston Scientific Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.2.5 Boston Scientific Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Sacral Nerve Stimulation Introduction
11.3.4 Abbott Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Axonics Modulation Technologies
11.4.1 Axonics Modulation Technologies Company Detail
11.4.2 Axonics Modulation Technologies Business Overview
11.4.3 Axonics Modulation Technologies Sacral Nerve Stimulation Introduction
11.4.4 Axonics Modulation Technologies Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.4.5 Axonics Modulation Technologies Recent Development
11.5 Nuvectra
11.5.1 Nuvectra Company Detail
11.5.2 Nuvectra Business Overview
11.5.3 Nuvectra Sacral Nerve Stimulation Introduction
11.5.4 Nuvectra Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.5.5 Nuvectra Recent Development
11.6 Cogentix Medical
11.6.1 Cogentix Medical Company Detail
11.6.2 Cogentix Medical Business Overview
11.6.3 Cogentix Medical Sacral Nerve Stimulation Introduction
11.6.4 Cogentix Medical Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.6.5 Cogentix Medical Recent Development
11.7 Cyberonics
11.7.1 Cyberonics Company Detail
11.7.2 Cyberonics Business Overview
11.7.3 Cyberonics Sacral Nerve Stimulation Introduction
11.7.4 Cyberonics Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.7.5 Cyberonics Recent Development
11.8 Uroplasty, Inc
11.8.1 Uroplasty, Inc Company Detail
11.8.2 Uroplasty, Inc Business Overview
11.8.3 Uroplasty, Inc Sacral Nerve Stimulation Introduction
11.8.4 Uroplasty, Inc Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.8.5 Uroplasty, Inc Recent Development
11.9 Neuropace
11.9.1 Neuropace Company Detail
11.9.2 Neuropace Business Overview
11.9.3 Neuropace Sacral Nerve Stimulation Introduction
11.9.4 Neuropace Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.9.5 Neuropace Recent Development
11.10 IntraPace, Inc
11.10.1 IntraPace, Inc Company Detail
11.10.2 IntraPace, Inc Business Overview
11.10.3 IntraPace, Inc Sacral Nerve Stimulation Introduction
11.10.4 IntraPace, Inc Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.10.5 IntraPace, Inc Recent Development
11.11 Codman & Shurtleff, Inc
11.11.1 Codman & Shurtleff, Inc Company Detail
11.11.2 Codman & Shurtleff, Inc Business Overview
11.11.3 Codman & Shurtleff, Inc Sacral Nerve Stimulation Introduction
11.11.4 Codman & Shurtleff, Inc Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.11.5 Codman & Shurtleff, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Sacral Nerve Stimulation Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Implantable SNS
Table 3. Key Players of External SNS
Table 4. Global Sacral Nerve Stimulation Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Sacral Nerve Stimulation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Sacral Nerve Stimulation Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Sacral Nerve Stimulation Market Share by Region (2019-2024)
Table 8. Global Sacral Nerve Stimulation Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Sacral Nerve Stimulation Market Share by Region (2025-2030)
Table 10. Sacral Nerve Stimulation Market Trends
Table 11. Sacral Nerve Stimulation Market Drivers
Table 12. Sacral Nerve Stimulation Market Challenges
Table 13. Sacral Nerve Stimulation Market Restraints
Table 14. Global Sacral Nerve Stimulation Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Sacral Nerve Stimulation Market Share by Players (2019-2024)
Table 16. Global Top Sacral Nerve Stimulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sacral Nerve Stimulation as of 2023)
Table 17. Ranking of Global Top Sacral Nerve Stimulation Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Sacral Nerve Stimulation Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Sacral Nerve Stimulation Product Solution and Service
Table 21. Date of Enter into Sacral Nerve Stimulation Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sacral Nerve Stimulation Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Sacral Nerve Stimulation Revenue Market Share by Type (2019-2024)
Table 25. Global Sacral Nerve Stimulation Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Sacral Nerve Stimulation Revenue Market Share by Type (2025-2030)
Table 27. Global Sacral Nerve Stimulation Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Sacral Nerve Stimulation Revenue Market Share by Application (2019-2024)
Table 29. Global Sacral Nerve Stimulation Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Sacral Nerve Stimulation Revenue Market Share by Application (2025-2030)
Table 31. North America Sacral Nerve Stimulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Sacral Nerve Stimulation Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Sacral Nerve Stimulation Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Sacral Nerve Stimulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Sacral Nerve Stimulation Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Sacral Nerve Stimulation Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Sacral Nerve Stimulation Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Sacral Nerve Stimulation Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Sacral Nerve Stimulation Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Sacral Nerve Stimulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Sacral Nerve Stimulation Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Sacral Nerve Stimulation Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Sacral Nerve Stimulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Sacral Nerve Stimulation Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Sacral Nerve Stimulation Market Size by Country (2025-2030) & (US$ Million)
Table 46. Medtronic Company Detail
Table 47. Medtronic Business Overview
Table 48. Medtronic Sacral Nerve Stimulation Product
Table 49. Medtronic Revenue in Sacral Nerve Stimulation Business (2019-2024) & (US$ Million)
Table 50. Medtronic Recent Development
Table 51. Boston Scientific Company Detail
Table 52. Boston Scientific Business Overview
Table 53. Boston Scientific Sacral Nerve Stimulation Product
Table 54. Boston Scientific Revenue in Sacral Nerve Stimulation Business (2019-2024) & (US$ Million)
Table 55. Boston Scientific Recent Development
Table 56. Abbott Company Detail
Table 57. Abbott Business Overview
Table 58. Abbott Sacral Nerve Stimulation Product
Table 59. Abbott Revenue in Sacral Nerve Stimulation Business (2019-2024) & (US$ Million)
Table 60. Abbott Recent Development
Table 61. Axonics Modulation Technologies Company Detail
Table 62. Axonics Modulation Technologies Business Overview
Table 63. Axonics Modulation Technologies Sacral Nerve Stimulation Product
Table 64. Axonics Modulation Technologies Revenue in Sacral Nerve Stimulation Business (2019-2024) & (US$ Million)
Table 65. Axonics Modulation Technologies Recent Development
Table 66. Nuvectra Company Detail
Table 67. Nuvectra Business Overview
Table 68. Nuvectra Sacral Nerve Stimulation Product
Table 69. Nuvectra Revenue in Sacral Nerve Stimulation Business (2019-2024) & (US$ Million)
Table 70. Nuvectra Recent Development
Table 71. Cogentix Medical Company Detail
Table 72. Cogentix Medical Business Overview
Table 73. Cogentix Medical Sacral Nerve Stimulation Product
Table 74. Cogentix Medical Revenue in Sacral Nerve Stimulation Business (2019-2024) & (US$ Million)
Table 75. Cogentix Medical Recent Development
Table 76. Cyberonics Company Detail
Table 77. Cyberonics Business Overview
Table 78. Cyberonics Sacral Nerve Stimulation Product
Table 79. Cyberonics Revenue in Sacral Nerve Stimulation Business (2019-2024) & (US$ Million)
Table 80. Cyberonics Recent Development
Table 81. Uroplasty, Inc Company Detail
Table 82. Uroplasty, Inc Business Overview
Table 83. Uroplasty, Inc Sacral Nerve Stimulation Product
Table 84. Uroplasty, Inc Revenue in Sacral Nerve Stimulation Business (2019-2024) & (US$ Million)
Table 85. Uroplasty, Inc Recent Development
Table 86. Neuropace Company Detail
Table 87. Neuropace Business Overview
Table 88. Neuropace Sacral Nerve Stimulation Product
Table 89. Neuropace Revenue in Sacral Nerve Stimulation Business (2019-2024) & (US$ Million)
Table 90. Neuropace Recent Development
Table 91. IntraPace, Inc Company Detail
Table 92. IntraPace, Inc Business Overview
Table 93. IntraPace, Inc Sacral Nerve Stimulation Product
Table 94. IntraPace, Inc Revenue in Sacral Nerve Stimulation Business (2019-2024) & (US$ Million)
Table 95. IntraPace, Inc Recent Development
Table 96. Codman & Shurtleff, Inc Company Detail
Table 97. Codman & Shurtleff, Inc Business Overview
Table 98. Codman & Shurtleff, Inc Sacral Nerve Stimulation Product
Table 99. Codman & Shurtleff, Inc Revenue in Sacral Nerve Stimulation Business (2019-2024) & (US$ Million)
Table 100. Codman & Shurtleff, Inc Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sacral Nerve Stimulation Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Sacral Nerve Stimulation Market Share by Type: 2023 VS 2030
Figure 3. Implantable SNS Features
Figure 4. External SNS Features
Figure 5. Global Sacral Nerve Stimulation Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Sacral Nerve Stimulation Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. ASCs Case Studies
Figure 10. Sacral Nerve Stimulation Report Years Considered
Figure 11. Global Sacral Nerve Stimulation Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Sacral Nerve Stimulation Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Sacral Nerve Stimulation Market Share by Region: 2023 VS 2030
Figure 14. Global Sacral Nerve Stimulation Market Share by Players in 2023
Figure 15. Global Top Sacral Nerve Stimulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sacral Nerve Stimulation as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Sacral Nerve Stimulation Revenue in 2023
Figure 17. North America Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Sacral Nerve Stimulation Market Share by Country (2019-2030)
Figure 19. United States Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Sacral Nerve Stimulation Market Share by Country (2019-2030)
Figure 23. Germany Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Sacral Nerve Stimulation Market Share by Region (2019-2030)
Figure 31. China Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Sacral Nerve Stimulation Market Share by Country (2019-2030)
Figure 39. Mexico Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Sacral Nerve Stimulation Market Share by Country (2019-2030)
Figure 43. Turkey Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Sacral Nerve Stimulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Medtronic Revenue Growth Rate in Sacral Nerve Stimulation Business (2019-2024)
Figure 46. Boston Scientific Revenue Growth Rate in Sacral Nerve Stimulation Business (2019-2024)
Figure 47. Abbott Revenue Growth Rate in Sacral Nerve Stimulation Business (2019-2024)
Figure 48. Axonics Modulation Technologies Revenue Growth Rate in Sacral Nerve Stimulation Business (2019-2024)
Figure 49. Nuvectra Revenue Growth Rate in Sacral Nerve Stimulation Business (2019-2024)
Figure 50. Cogentix Medical Revenue Growth Rate in Sacral Nerve Stimulation Business (2019-2024)
Figure 51. Cyberonics Revenue Growth Rate in Sacral Nerve Stimulation Business (2019-2024)
Figure 52. Uroplasty, Inc Revenue Growth Rate in Sacral Nerve Stimulation Business (2019-2024)
Figure 53. Neuropace Revenue Growth Rate in Sacral Nerve Stimulation Business (2019-2024)
Figure 54. IntraPace, Inc Revenue Growth Rate in Sacral Nerve Stimulation Business (2019-2024)
Figure 55. Codman & Shurtleff, Inc Revenue Growth Rate in Sacral Nerve Stimulation Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
